NSB 2.50% 3.9¢ neuroscientific biopharmaceuticals ltd

Potential 100 bagger Biotech missed by the market, page-1358

  1. 125 Posts.
    lightbulb Created with Sketch. 228
    I did a post for new investors here

    Look at the chart, the reason for the drop is trial delays (IMO) as before that the share price was increasing in anticipation, this is a great accumulation opportunity, once trials begin next year we will be back into the 50s
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.